Psychometric validation of the revised Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) quality of life instrument

被引:100
作者
Peterman, AH [1 ]
Cella, D [1 ]
Mo, F [1 ]
McCain, N [1 ]
机构
[1] VIRGINIA COMMONWEALTH UNIV,SCH NURSING,RICHMOND,VA 23284
关键词
QoL; HIV/AIDS; psychometrics;
D O I
10.1023/A:1018416317546
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
The revised Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) quality of life (QoL) instrument has been updated and expanded to provide more complete and accurate coverage of human immune deficiency virus/ acquired immune deficiency syndrome (HIV/AIDS)related QoL. Factor analysis and the Rasch measurement model were used to determine a new subscale structure for the FAHI. The content of these subscales, including physical well-being (ten items, alpha = 0.91), function and global well-being (13 items, alpha = 0.86), emotional well-being/living with HIV (10 items, alpha = 0.82), social well-being (eight items, alpha = 0.73), and cognitive functioning (three items; alpha = 0.75), reflect both general illness-and HIV/AIDS-specific QoL concerns: a total QoL score can also be calculated for the FAHI (44 items, alpha = 0.91). Psychometric evaluation revealed good internal consistency reliability for the FAHI and its subscales. In addition, construct validity, known groups validity and sensitivity to change were demonstrated by significant associations between the FAHI and additional indicators of functional status, psychological symptoms, stress and illness severity. In summary, the FAHI is a psychometrically sound instrument that captures multiple important dimensions of HIV/AIDS-related QoL. It is brief, easy to administer and score, has been translated into nine languages other than English and is appropriate for use in clinical trials and clinical practice.
引用
收藏
页码:572 / 584
页数:13
相关论文
共 28 条
  • [1] THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY
    AARONSON, NK
    AHMEDZAI, S
    BERGMAN, B
    BULLINGER, M
    CULL, A
    DUEZ, NJ
    FILIBERTI, A
    FLECHTNER, H
    FLEISHMAN, SB
    DEHAES, JCJM
    KAASA, S
    KLEE, M
    OSOBA, D
    RAZAVI, D
    ROFE, PB
    SCHRAUB, S
    SNEEUW, K
    SULLIVAN, M
    TAKEDA, F
    [J]. JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) : 365 - 376
  • [2] RATING FORMULATION FOR ORDERED RESPONSE CATEGORIES
    ANDRICH, D
    [J]. PSYCHOMETRIKA, 1978, 43 (04) : 561 - 573
  • [3] [Anonymous], 1980, PROBABILISTIC MODELS
  • [4] Cattell R., 2012, SCI USE FACTOR ANAL
  • [5] Development and validation of the functional assessment of human immunodeficiency virus infection (FAHI) quality of life instrument
    Cella, DF
    McCain, NL
    Peterman, AH
    Mo, F
    Wolen, D
    [J]. QUALITY OF LIFE RESEARCH, 1996, 5 (04) : 450 - 463
  • [6] A BRIEF POMS MEASURE OF DISTRESS FOR CANCER-PATIENTS
    CELLA, DF
    JACOBSEN, PB
    ORAV, EJ
    HOLLAND, JC
    SILBERFARB, PM
    RAFLA, S
    [J]. JOURNAL OF CHRONIC DISEASES, 1987, 40 (10): : 939 - 942
  • [7] THE FUNCTIONAL ASSESSMENT OF CANCER-THERAPY SCALE - DEVELOPMENT AND VALIDATION OF THE GENERAL MEASURE
    CELLA, DF
    TULSKY, DS
    GRAY, G
    SARAFIAN, B
    LINN, E
    BONOMI, A
    SILBERMAN, M
    YELLEN, SB
    WINICOUR, P
    BRANNON, J
    ECKBERG, K
    LLOYD, S
    PURL, S
    BLENDOWSKI, C
    GOODMAN, M
    BARNICLE, M
    STEWART, I
    MCHALE, M
    BONOMI, P
    KAPLAN, E
    TAYLOR, S
    THOMAS, CR
    HARRIS, J
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (03) : 570 - 579
  • [8] CELLA DF, 1996, FACT MANUAL MANUAL F
  • [9] CELLA DF, 1995, QUALITY LIFE PHARMAC, P203
  • [10] *CTR DIS CONTR, 1992, MMWR-MORBID MORTAL W, P41